Calendar Oncotelic Therapeutics, Inc.

Equities

OTLC

US6283411097

Market Closed - OTC Markets 18:46:10 10/05/2024 BST 5-day change 1st Jan Change
0.0382 USD -1.29% Intraday chart for Oncotelic Therapeutics, Inc. -2.79% 0.00%

Chart calendar Oncotelic Therapeutics, Inc.

ddfd34c5a2679f6a2d87e9f936b67.vGn19-h2oV0h6vwZh2zGhlcYGV-vsRzYccHRbqa4h4M.9j62h4kc7xdpuJ174TqksCVUbCvn3H_rFbeYJMDh1NfzPoe03DnON0rfuQ~6e488e0d363404e6fa8eace761f7bbc9

Upcoming events on Oncotelic Therapeutics, Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
14/08/2024 Q2 2024 Earnings Release (Projected)
17/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Oncotelic Therapeutics, Inc.

07/05/2024 Biopharma Nexus Conference
14/04/2024 Q4 2023 Earnings Release (Projected)
28/11/2023 Ibero American Chatbot and Conversational AI Summit
15/11/2023 14:00 Q3 2023 Earnings Release
17/08/2023 Q2 2023 Earnings Release
04/06/2023 BIO International Convention
17/04/2023 12:00 Q4 2022 Earnings Release
21/11/2022 14:00 Q3 2022 Earnings Release
19/11/2022 00:30 Society for Neuro Oncology Meeting - Abstract No DDEL 16
19/11/2022 00:30 Society for Neuro Oncology Meeting - Abstract No RTID 04
10/11/2022 13:00 Society for Immunotherapy of Cancer Meeting - Abstract No 599
28/08/2022 Biotechgate Digital Partnering Conference
22/08/2022 14:00 Interim 2022 Earnings Release
07/07/2022 JCA-AACR Special Joint Conference
12/06/2022 BIO International Convention
15/05/2022 Q1 2022 Earnings Release (Projected)
18/04/2022 12:00 FY 2021 Earnings Release
07/04/2022 American Association of Cancer Research Meeting - Abstract No-2937
27/03/2022 MedInvest Pharmaceutical and Biotechnology Investor Conference
24/01/2022 TGF-? for Immuno-Oncology Drug Development Summit

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
1,74
1,72
1.18%
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-7,55
-5,79
-30.42%
-9,06
-10,5
14.03%
-5,60
8,59
-165.15%
EBIT
Million USD
Released
Forecast
Spread
-7,58
-5,93
-28%
-9,13
-9,81
6.98%
-9,72
-5,80
-67.73%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,97
-8,28
-20.42%
-10,5
-10,6
1.1%
4,68
8,50
-44.99%
Net income
Million USD
Released
Forecast
Spread
-9,50
-8,28
-14.75%
-9,39
-10,6
11.69%
5,09
8,50
-40.07%
EPS
USD
Released
Forecast
Spread
-0,11
-0,08
-37.5%
-0,03
-0,04
25%
0,01
0,02
-50%
Announcement Date15/04/2115/04/2214/04/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-
0,07
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-1,51
-2,20
31.14%
-4,34
-1,90
-128.64%
-0,26
-1,90
86.51%
-0,60
-0,24
-148.1%
-4,53
-0,60
-654.28%



-0,24
-0,30
20.41%
0,01
-0,30
104.83%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-2,92
-2,70
-8.16%
-5,09
-1,90
-167.91%
16,0
-1,90
940.56%
-0,86
-1,24
30.69%
-5,34
-1,60
-234.02%
-0,53


-6,85
-0,40
-1612.5%
0,04
-0,40
110.27%
Net income
Million USD
Released
Forecast
Spread
-1,79
-2,70
33.55%
-4,85
-1,90
-155.25%
16,0
-1,90
942.74%
-0,78
-1,24
37.26%
-5,29
-1,60
-230.59%
-0,53


-6,85
-0,40
-1612.5%
0,12
-0,40
128.83%
EPS
USD
Released
Forecast
Spread
0,00
-0,01
-
-0,01
-0,01
0%
0,04
0,00
-
0,00
0,00
-
-0,01
0,00
-



-0,02
0,00
-
0,00
0,00
-
Announcement Date15/04/2223/05/2222/08/2218/11/2214/04/2322/05/2318/08/2314/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OTLC Stock
  4. Calendar Oncotelic Therapeutics, Inc.